Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes?

Pediatric blood & cancer

Volumn 63, Issue 5, 2016, Pages 844-847

  Creary, Susan E ^a   Chisolm, Deena J ^a   Koch, Terah L ^a   Zigmont, Victoria A ^a   Lu, Bo ^a   O'Brien, Sarah H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Hematology; hydroxyurea; nonmalignant; sickle cell disease

Indexed keywords

HYDROXYUREA;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CLINICAL TRIAL; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROXYUREA; MALE; PATIENT ADMISSION; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84985901369     PISSN: None     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25894     Document Type: Article

References (0)